NLS Pharmaceutics
NLSP
NLSP
9 hedge funds and large institutions have $7.11M invested in NLS Pharmaceutics in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
26% less capital invested
Capital invested by funds: $9.62M → $7.11M (-$2.51M)
Holders
9
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$61.5K | |
| 2 | +$40.8K | |
| 3 | +$24.8K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$3.75K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$110 |